Search
    Skip to main content
    Advertisement

    Eli Lilly

    1. Business
    2. Pharmaceuticals
    3. Eli Lilly
    FDA approves expanded use of Eli Lilly's ulcerative colitis drug for Crohn's disease Benzinga08:06
    Could Donald trump make Eli Lilly stock a no-brainer buy in 2025? The Motley Fool04:10
    Eli Lilly stock slumps on lowered sales forecast Investopedia18:05
    Eli Lilly: Big 2025 Ahead, But Execution Risks Exist Seeking Alpha16:59
    Eli Lilly cuts Q4 sales forecast, but analyst remains bullish on stock—here’s why Invezz15:18
    Eli Lilly adjusts outlook, CEO David Ricks explains revenue shortfall Benzinga14:42
    Nvo, vktx stocks fall as Lilly's Zepbound, Mounjaro sales slow down Zacks13:05

    Latest News

    In the last 6 hours
    Why Eli Lilly Stock Topped the Market Today The Motley Fool17:31
    Earlier today
    Novo shares climb on early data for dual-acting obesity drug BioPharma Dive12:23
    Why Novo Nordisk surged 14% on new weight-loss drug results Invezz11:29
    R/GA Wins Eli Lilly Social Business Amid Weight-Loss Drug Boom Adweek08:19
    Yesterday
    Premature Ejaculation Treatment Market to Grow by USD 1.53 Billion (2025-2029), Off-Label Drug… PR Newswire (Press Release)23:20 23-Jan-25
    Investors lose their appetite for the obesity trade New Zealand Herald18:13 23-Jan-25
    Lilly confirms date and conference call for fourth-quarter 2024 financial results and 2025… PR Newswire (Press Release)10:03 23-Jan-25
    Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is the Stock in Trouble? The Motley Fool06:24 23-Jan-25
    The Zacks Analyst Blog Eli Lilly, Exxon Mobil, Costco and Flanigan's Zacks04:03 23-Jan-25
    In the last 7 days
    This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider 24/7 Wall St.11:24 22-Jan-25
    It's about to get a lot harder to buy knock-off Ozempic Business Insider04:53 22-Jan-25
    Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To… Benzinga01:53 22-Jan-25
    Stock Of The Day: Lilly's Strong Support Level Signals Potential Rebound Benzinga11:28 21-Jan-25
    Eli Lilly: Market Overreacted Seeking Alpha11:16 21-Jan-25
    Novo Nordisk and Eli Lilly (NYSE:LLY) Weight Loss Drugs “Reduce Risk of Alzheimer’s” TipRanks06:36 21-Jan-25
    2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs MorningStar.com22:12 20-Jan-25
    Should You Buy the Dip in Eli Lilly Stock Right Now? The Motley Fool05:16 19-Jan-25
    Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried? The Motley Fool04:25 19-Jan-25
    Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity? The Motley Fool06:12 18-Jan-25
    Eli Lilly Faces ‘Death Cross’ Selloff: This is the Stock's Next Target Price... Money Morning18:20 17-Jan-25
    Pharma company Eli Lilly signs €750,000 collaboration with Family Carers Ireland Limerick Post10:08 17-Jan-25
    FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease Benzinga08:06 17-Jan-25
    Mega M&A at JP Morgan Conference 2025 — is biopharma M&A poised for a rebound? Pharmaceutical Technology07:08 17-Jan-25
    Could Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025? The Motley Fool04:10 17-Jan-25
    In the last month
    FDA Approves Omvoh for Moderately to Severely Active Crohn Disease HealthDay18:12 16-Jan-25
    Eli Lilly Stock Slumps on Lowered Sales Forecast Investopedia18:05 16-Jan-25
    Eli Lilly’s Omvoh granted FDA approval to treat Crohn’s disease in adults PMLiVE07:44 16-Jan-25
    Lilly nets a second FDA okay for Omvoh, in Crohn's disease pharmaphorum05:07 16-Jan-25
    Hanmi seeks to gain on Wegovy with its own weight-loss drug Korea JoongAng Daily23:27 15-Jan-25
    Eli Lilly's Omvoh earns FDA approval for Crohn's disease ENDPOINTS17:17 15-Jan-25
    Eli Lilly: Big 2025 Ahead, But Execution Risks Exist Seeking Alpha16:59 15-Jan-25
    Eli Lilly cuts Q4 sales forecast, but analyst remains bullish on stock—here’s why Invezz15:18 15-Jan-25
    Eli Lilly Adjusts Outlook, CEO David Ricks Explains Revenue Shortfall Benzinga14:42 15-Jan-25
    NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down Zacks13:05 15-Jan-25
    Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip Barchart12:11 15-Jan-25
    See Which Of The Latest 13F Filers Holds Eli Lilly Nasdaq09:54 15-Jan-25
    Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss? 24/7 Wall St.09:09 15-Jan-25
    Has Eli Lilly Stock Peaked? The Motley Fool08:23 15-Jan-25
    Lilly trims sales forecast on weaker obesity/diabetes growth pharmaphorum08:04 15-Jan-25
    Here’s why Eli Lilly stock is crashing Finance in Bold07:43 15-Jan-25
    JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400m Pharmaceutical Technology06:40 15-Jan-25
    Trending tickers: Meta, Tesla, Eli Lilly, Currys and Vistry Yahoo! UK & Ireland05:56 15-Jan-25
    The Zacks Analyst Blog Highlights J&J, Eli Lilly, GSK and Intra-Cellular Zacks04:07 15-Jan-25
    Eli Lilly Misses Drug Sales Forecast, Shares Drop Over 8% Barchart21:14 14-Jan-25
    Dispute Over Eli Lilly Weight Loss Drug Reignited Law36020:33 14-Jan-25
    JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning BioPharma Dive18:10 14-Jan-25
    JPM25: Eli Lilly's preliminary '24 sales figures show a continued easing in breakneck GLP-1… FiercePharma16:42 14-Jan-25
    How major US stock indexes fared Tuesday, 1/14/2025 Yahoo! US16:23 14-Jan-25
    Eli Lilly Says Colo. Clinic Selling Deceptive Weight Loss Drug Law36015:47 14-Jan-25
    Eli Lilly misses 2024 revenue expectations, stock dips 7% ENDPOINTS15:41 14-Jan-25
    Market movers: Eli Lilly, Signet Jewelers, Volta Metals... Proactive Investors (US)15:30 14-Jan-25
    Eli Lilly stock tumbles after new forecasts show weight-loss drug sales grow slower than… Yahoo! UK & Ireland15:19 14-Jan-25
    Eli Lilly stumbles as weight-loss drug sales less than expected Proactive Investors (US)14:09 14-Jan-25
    Eli Lilly stock down on Q4 guidance miss Yahoo! UK & Ireland14:08 14-Jan-25
    Eli Lilly lowers FY revenue forecast as weight loss drug sales fall short Proactive Investors (US)13:18 14-Jan-25
    Top Stock Movers Now: United Rentals, KB Home, Eli Lilly, and More Investopedia12:18 14-Jan-25
    Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday The Motley Fool12:12 14-Jan-25
    Eli Lilly was hoping for even greater weight loss drug demand Quartz11:25 14-Jan-25
    China stocks, Trump Media shares, Eli Lilly: Market Minute Yahoo! UK & Ireland11:25 14-Jan-25
    Eli Lily cuts 2024 revenue guidance by $400M, shares sink 8% Invezz11:16 14-Jan-25
    Eli Lilly misses 2024 revenue numbers, but GLP-1 pill may help Yahoo! US11:07 14-Jan-25
    Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks Benzinga10:23 14-Jan-25
    Lilly Sales Miss on Slower-Than-Expected Obesity Shot Demand Yahoo! UK & Ireland10:14 14-Jan-25
    Eli Lilly forecasts weaker Q4 sales of weight-loss drug, Mounjaro than expected Yahoo! UK & Ireland09:43 14-Jan-25
    Watch These Eli Lilly Price Levels as Stock Slumps on Tepid Sales Outlook Investopedia08:00 14-Jan-25
    S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook Weakens Investopedia08:00 14-Jan-25
    Eli Lilly to acquire Scorpion’s solid tumour programme in deal worth $2.5bn PMLiVE07:24 14-Jan-25
    Eli Lilly targets Scorpion Therapeutics to expand reach in oncology Pharmaceutical Technology18:36 13-Jan-25
    Lilly nets Scorpion cancer drug in $2.5bn licensing deal pharmaphorum15:52 13-Jan-25
    Eli Lilly's weight loss pill could get federal approval by early next year Quartz11:49 13-Jan-25
    Eli Lilly Scoops Up Scorpion Therapeutics' Early-Stage Cancer Program For $2.5 Billion Benzinga10:42 13-Jan-25
    JPM25: Eli Lilly strikes $2.5B Scorpion buyout in twist to breast cancer tale FierceBiotech10:12 13-Jan-25
    Eli Lilly to buy cancer drugmaker Scorpion Therapeutics for up to $2.5 bn The Business Standard10:04 13-Jan-25
    Eli Lilly to buy cancer drug developer Scorpion Therapeutics for up to $2.5 billion Yahoo! UK & Ireland09:16 13-Jan-25
    Eli Lilly's Q4 2024 Earnings: What to Expect Barchart05:00 13-Jan-25
    Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment Pharmaceutical Technology04:31 13-Jan-25
    Eli Lilly: Still Expensive As Earnings Near, But Not Worthy Of A Downgrade Seeking Alpha15:18 11-Jan-25
    Eli Lilly: Still Much Room To Ride The Weight-Loss Wave Seeking Alpha12:18 11-Jan-25
    Eli Lilly, Andreessen Horowitz link up on $500M biotech venture fund FierceBiotech11:12 10-Jan-25
    Eli Lilly pushes into pulmonary fibrosis with $99M deal for Mediar's midphase prospect FierceBiotech08:49 10-Jan-25
    Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Venture… Business Wire (Press Release)08:49 10-Jan-25
    Announcement: Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Fund Andreessen Horowitz08:29 10-Jan-25
    Eli Lilly and Alchemab Therapeutics partner to develop new ALS therapies PMLiVE07:49 10-Jan-25
    Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli… GlobeNewswire (Press Release)04:13 10-Jan-25
    Eli Lilly setting up GCC in Hyderabad, to hire over 1,000 people The Hindu01:33 10-Jan-25
    Eli Lilly (LLY) Vs Novo Nordisk (NVO): Which is the Best Weight Loss Stock for 2025? Barchart21:25 9-Jan-25
    Eli Lilly's Zepbound Can Now Be Covered by Medicare to Treat Sleep Apnea Yahoo! US16:29 9-Jan-25
    Eli Lilly’s new GCC to boost digital strategy & innovation The Times of India14:45 9-Jan-25
    Biocom California Appoints New Members to its Board of Directors Business Wire (Press Release)11:09 9-Jan-25
    US pharma major Eli Lilly to establish second Indian GCC in Hyderabad The Business Standard09:28 9-Jan-25
    Medicare To Cover Eli Lilly's Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment Benzinga09:22 9-Jan-25
    Exclusive: Arianna Huffington’s Thrive Global inks novel partnership with pharma giant Eli Lilly Fortune08:47 9-Jan-25
    Eli Lilly and Alchemab Therapeutics team up to discover and develop ALS antibodies Manufacturing Chemist07:53 9-Jan-25
    Eli Lilly’s Zepbound obesity drug covered by Medicare for sleep apnea Proactive Investors (US)07:13 9-Jan-25
    Eli Lilly to set up global capability centre in Hyderabad, hire over 1,000 people ThePrint05:53 9-Jan-25
    Eli Lilly and Company to set up global capability centre in Hyderabad, hire over 1,000 people The Telegraph, Calcutta04:42 9-Jan-25
    US pharma major Eli Lilly and Co plans to establish new GCC in Hyderabad The Economic Times04:01 9-Jan-25
    Eli Lilly to set up global capability centre in Hyderabad, hire 1K people The Business Standard03:51 9-Jan-25
    Eli Lilly to launch new capability centre in Hyderabad, hiring over 1,000 skilled professionals The Hindu Business Line03:02 9-Jan-25
    Eli Lilly launches atopic dermatitis drug Ebglyss in Korea Korea Biomedical Review02:58 9-Jan-25
    Eli Lilly to Launch GCC in Hyderabad, Plans to Employ Over 1,000 Professionals Analytics India Magazine02:24 9-Jan-25
    US pharma major Eli Lilly to set up GCC in Hyd The Times of India14:27 8-Jan-25
    Best Healthcare Stock to Buy: Eli Lilly vs. Novo Nordisk The Motley Fool10:34 8-Jan-25
    This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly The Motley Fool09:53 8-Jan-25
    Eli Lilly Allowed to Join Weight Loss Drug Compounding Lawsuit Bloomberg Law10:48 7-Jan-25
    Lilly to participate in J.P. Morgan Healthcare Conference PR Newswire (Press Release)10:06 7-Jan-25
    Family Carers Ireland announces transformative collaboration with Eli Lilly to support carers Limerick Leader09:11 7-Jan-25
    Novo Nordisk Poised for Short-Term Gains, while Eli Lilly Promises Stronger Long-Term Growth TipRanks08:28 7-Jan-25
    Novo Nordisk Vs. Eli Lilly: Obesity Makes Their Future Bright, But One Of Them Has More Potential Seeking Alpha19:51 6-Jan-25
    Danish biotech Orbis secures $94m to develop oral versions of biologics Pharmaceutical Technology13:51 6-Jan-25
    Why 2025 will be an inflection for Novo Nordisk, Eli Lilly's GLP-1s Yahoo! UK & Ireland13:01 6-Jan-25
    Florida car dealer joins insulin pricing fight against Eli Lilly, Sanofi ENDPOINTS14:30 3-Jan-25
    Eli Lilly seeks to join lawsuit over end of tirzepatide shortage ENDPOINTS13:18 3-Jan-25
    FDA Announced Removal of Tirzepatide from the Drug Shortage List JD Supra12:46 3-Jan-25
    Trump May Revisit Most Favored Nation Model for Prescription Drug Prices Forbes12:13 3-Jan-25
    view more headlines
    24 Jan 17:31

    About our Eli Lilly news

    Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

    Pharmaceuticals Top Stories

    FDA & EMA accept Biogen's filings for higher dose SMA drug Zacks05:30
    FDA sheds light on new Drug approvals in breast cancer Pharmacy Times09:41
    FDA approves drug application for Lupin’s heart failure therapy Pharmaceutical Technology09:28
    Biogen CEO tells Governor Healey he’s concerned about ‘a lot more policy risk’ in D.C. Boston Globe09:17
    Novo Nordisk stock surges 12% as an Ozempic alternative shows promising weight loss Quartz09:06

    Business Top Stories

    Target becomes the latest brand to roll back DEI Bellingham Herald21:14Costco DEI
    Costco shareholders reject anti-DEI measure Fox News15:52Costco DEI
    Major victory: SEC repeals controversial crypto rule SAB 121 Wall Street Pit15:55SEC Crypto Business (US)
    SEC unwinds crypto accounting, but regulatory questions remain Bloomberg Law18:35SEC Crypto Business (US)
    Verizon earnings: Additional price increases should drive modest growth MorningStar.com17:29Verizon Business (US)
    Why Verizon stock is gaining today The Motley Fool12:37Verizon Business (US)
    Meta plans to spend as much as $65B in 'Defining year for AI' says Zuckerberg Yahoo! US19:03Mark Zuckerberg Meta AI
    Meta plans $65 billion Infrastructure Investment during ‘Defining year’ for AI PYMNTS.com19:17Mark Zuckerberg Meta AI
    Novo Nordisk: Next-generation GLP-1/amylin drug sees leading weight loss in small trial MorningStar.com16:39Novo Nordisk Ozempic Pharma
    Novo Nordisk stock surges on weight loss drug data and analysts say it's still a Buy Kiplinger.com11:41Novo Nordisk Ozempic Pharma
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.